ArisGlobal has opened up new opportunities for clinical trial sponsors to use agDisclosure to meet trial registration and disclosure requirements at no cost.
ArisGlobal, a leading provider of solutions to the life science industry has opened up new opportunities for clinical trial sponsors to use agDisclosureTM to meet trial registration and disclosure requirements at no cost. With the release of agDisclosure™ Basic Edition, the company offers a free, entry-level version of its full product in support of trial registration and results disclosure to ClinicalTrials.gov.
agDisclosure Basic Edition is the first and only cloud-based offering that gives life science organizations a no-cost way to efficiently manage the trial registration and results disclosure process for ClinicalTrials.gov. Planning and tracking as well as configurable review and approval workflow functionality ensure the quality, consistency and integrity of data before it is submitted. Pre-recorded training and a user guide enable users to become productive quickly. Interested companies can learn more about this free version at http://totalclinical.com/agdisclosure-free-basic-edition.
“While there are good reasons for making the disclosure of protocol and results data mandatory, the increasing transparency requirements add to the administrative burdens around conducting clinical trials,” states Mathias Poensgen, Product Manager, ArisGlobal. “agDisclosure helps to keep these administrative costs under control by making the trial registration and disclosure process as efficient as possible. Using agDisclosure Basic Edition, companies can experience and evaluate the value this solution delivers over managing the disclosure process manually or using an in-house solution at no cost to their organization.”
The Basic Edition is an entry-level version of the agDisclosure Enterprise Edition, an extended solution that supports trial registration and results reporting to ClinicaTrials.gov, EudraCT and other global registries. The Enterprise Edition, (offered either on premise or hosted on the cloud), provides fuller functionality, including the ability to re-use one entry multiple times across different registries and seamless integration with any CTMS.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.